new
antiaid
treatment
must
continu
develop
order
overcom
resist
mutat
includ
emerg
newest
therapeut
target
viral
integras
multimer
function
imper
provid
forthcom
therapeut
target
alloster
inhibitor
bind
noncatalyt
site
prevent
correct
multimer
restrict
viral
integr
also
assembl
matur
viral
particl
report
alloster
inhibitor
peptid
target
unexploit
platform
retrovir
crystal
structur
peptid
complex
core
domain
reveal
steric
interfer
would
inhibit
conserv
dock
domain
core
domain
vital
multimer
provid
templat
develop
novel
antiin
alloster
inhibitor
absenc
cur
treatment
highli
activ
antiretrovir
therapi
haart
keep
viru
aid
patient
control
haart
combin
drug
target
differ
stage
viral
replic
includ
integr
step
catalyz
integras
protein
integr
viral
dna
host
genom
involv
two
step
catalyz
cleavag
dinucleotid
viral
dna
ii
insert
process
viral
dna
host
dna
strandtransf
clinic
strand
transfer
inhibitor
insti
target
catalyt
site
enzym
specif
inhibit
dna
join
reaction
howev
antiaid
treatment
continu
success
drug
persist
disrupt
resist
mutat
although
carri
monomer
assembl
function
multim
imper
strandtransf
activ
viru
particl
matur
product
review
continu
quest
identifi
develop
new
drug
alloster
inhibitor
bind
site
outsid
catalyt
core
disrupt
multimer
emerg
potent
therapeut
potenti
tetram
form
reciproc
swap
three
ntermin
catalyt
core
ctermin
canon
domain
two
intern
protom
catalyt
bind
viral
host
dna
take
place
make
major
tetram
interfac
outer
two
protom
surround
unit
higher
order
assembl
provid
support
domain
indispens
assembl
tetramer
core
recent
show
target
interfac
ntermin
domain
ntd
catalyt
core
domain
ccd
use
specif
antigenbind
fragment
fab
inhibit
tetram
format
consequ
enzymat
activ
viru
particl
product
disrupt
dimer
elementari
dimer
block
build
tetram
also
explor
strategi
inhibit
activ
hinder
assembl
function
multim
one
side
coin
alloster
interfer
also
shown
promot
format
aberr
multim
aggreg
potenti
alloster
inhibitor
demonstr
thorough
character
ledgf
pocket
form
dimer
interfac
develop
ledgin
allini
inhibitor
bind
figur
although
less
investig
pocket
capabl
alloster
inhibitor
bind
also
identifi
figur
bind
molecul
pocket
near
ntermin
end
ccd
design
shown
inhibit
strandtransf
activ
sucros
bind
pocket
found
along
ccd
dimer
interfac
flank
two
ledgf
pocket
recent
target
natur
product
kuwanonl
inhibit
activ
pattern
similar
ledgin
anoth
fragmentbind
pocket
fbp
also
identifi
ccd
dimer
interfac
although
inhibitori
profil
fbp
pocket
shown
previou
work
felin
viru
show
singl
mutat
around
site
inhibit
dimer
format
fragmentbas
screen
structur
studi
reveal
capabl
three
pocket
fbp
ledgf
bind
numer
small
molecul
recent
new
class
ledgin
shown
distinct
bind
undefin
interfac
ccd
ctd
therefor
harbor
sever
alloster
hotspot
explor
novel
antimultimer
intervent
strategi
base
structur
fab
specif
ccdntd
platform
develop
peptid
similar
fab
inhibit
multimer
strandtransf
activ
surprisingli
crystal
structur
affin
experi
show
peptid
interfer
ccdctd
interfac
structur
featur
overlook
platform
crucial
multimer
provid
templat
screen
develop
novel
antiin
alloster
inhibitor
within
function
tetram
ntd
ctd
one
dimer
wrap
around
extend
ccd
second
dimer
figur
interdomaindock
platform
function
imper
previous
show
complementaritydefin
region
antiin
fab
wrap
around
ccd
residu
dock
cleft
rim
ccd
finger
loop
residu
figur
deriv
peptid
wsyfydgsysyydyesi
mostli
repres
sequenc
underlin
addit
trp
uvvi
absorb
sertyr
repres
extens
wrap
around
similar
parent
fab
peptid
inhibit
strandtransf
activ
figur
suggest
potenti
interfer
function
multimer
evalu
effect
peptid
multimer
use
chemic
crosslink
found
peptid
inde
interfer
multimer
figur
underscor
alloster
potenti
site
target
peptid
clarifi
inhibit
multimer
activ
parent
fab
specif
local
alloster
interfer
artifact
bulkier
size
whole
fab
character
peptid
bind
site
solv
crystal
structur
ccd
complex
peptid
except
ctermin
pair
residu
sertyr
welldefin
electron
densiti
show
bind
peptid
molecul
two
site
call
figur
examin
avail
structur
variou
function
multim
underscor
conserv
two
ccdctd
dock
platform
figur
tetram
interfac
form
ctd
flank
protom
dock
carboxylterminu
ccd
inner
protom
figur
form
dock
ctd
anoth
flank
protom
aminoterminu
figur
surfac
area
buri
upon
peptid
bind
larger
compar
peptid
bind
also
involv
higher
number
interact
residu
interfac
compar
side
chain
two
residu
peptid
particip
direct
hydrogen
bond
ccd
side
chain
carbonyl
oxygen
addit
hydrogen
bond
directli
form
backbon
peptid
one
three
water
molecul
mediat
addit
interact
site
two
one
figur
interestingli
carbonyl
oxygen
ccd
make
hydrogen
bond
peptid
also
make
hydrogen
bond
ctd
function
multim
discuss
figur
shown
posit
charg
posit
crucial
viral
replic
produc
replic
defect
virus
wherea
peptid
mainli
repres
expect
also
repres
bind
pattern
dock
ccdntd
interfac
finger
loop
figur
peptid
surprisingli
dock
underneath
mostli
resembl
bind
figur
superimpos
ccdpeptid
structur
onto
intasom
reveal
potenti
steric
interfer
ccd
dock
platform
ctd
ntd
figur
top
similarli
symmetri
relat
molecul
peptid
bound
reveal
potenti
interfer
dock
anoth
ctd
figur
bottom
demonstr
abil
fragment
specif
interfer
ccdctd
dock
consequ
inhibit
multimer
evalu
inhibitori
effect
specif
bind
inde
use
chemic
crosslink
show
attenu
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
multimer
dosedepend
manner
figur
corrobor
potenti
bound
peptid
inhibit
multimerizaion
therefor
peptid
bind
either
site
would
inhibit
ctd
interact
ccd
ration
observ
inhibit
multimer
figur
strandtransf
activ
figur
worth
note
sinc
dock
site
involv
ctd
also
ntd
linker
segment
residu
figur
peptid
bind
would
also
interfer
vital
dock
ntd
multimer
compet
peptidebound
activ
indic
peptid
bind
restrict
catalyt
loop
flexibl
densiti
map
miss
residu
induc
inactiv
conform
chang
enzym
rootmensquar
deviat
rmsd
apo
pdb
code
higher
number
interact
larger
surfac
area
buri
upon
peptid
bind
may
highlight
bind
privileg
site
analys
crystal
structur
truncat
variant
shown
dimer
ccd
ccdctd
tetramer
ntdccd
solut
crystal
show
clear
exposur
access
figur
b
wherea
also
expos
crystal
structur
dimer
ccd
tetramer
ntdccd
figur
analys
ccdctd
crystal
structur
intriguingli
show
ctd
constantli
dock
albeit
variou
configur
distinct
function
intasom
figur
orang
cartoon
inde
ctd
preoccupi
within
truncat
ccdctd
variant
seen
crystal
structur
expect
unlik
ccd
ntdccd
variant
ccdctd
construct
would
bind
peptid
assess
peptidebind
affin
variou
construct
show
presenc
ntd
within
ntdccd
slightli
fold
interfer
peptid
bind
figur
ctd
within
ccdctd
hand
almost
complet
abolish
peptid
bind
fold
figur
agreement
bind
data
structur
superimposit
peptid
show
ntd
ntdccd
structur
may
delic
interfer
peptid
bind
figur
ctd
ccdctd
structur
would
provid
robust
interfer
figur
worth
note
peptid
bound
fulllength
preassembl
tetram
solut
affin
kd
nm
correspond
concentr
monomer
assay
figur
fold
weaker
ntdccd
kd
nm
figur
togeth
ntd
appear
crucial
modul
ctd
interact
ccd
ctd
preoccup
twodomain
ccdctd
construct
may
signific
implic
physiolog
aberr
interact
mediat
ctd
domain
incompet
ccdctd
variant
activ
indic
ccdctd
configur
seen
crystal
structur
construct
figur
aberr
conceiv
interdomain
interact
especi
provid
ntd
miss
ccdctd
requir
correct
ctd
interact
maintain
catalyt
site
enzym
access
catalyt
activ
gain
insight
interact
made
ntd
ctd
interfer
catalyt
activ
ccd
assess
activ
truncat
domain
variant
truncat
variant
activ
strandtransf
activ
result
also
valid
shown
found
wherea
ccd
residu
ntdccd
residu
variant
compet
activ
fulllength
enzym
ccdctd
residu
inde
defect
figur
inhibitori
effect
ctd
part
ccdctd
diminish
upon
separ
ctd
segment
residu
supplement
ccd
protein
reaction
mixtur
figur
ccdctd
furthermor
addit
ctd
reaction
contain
separ
ccd
ntd
residu
figur
ccdntd
found
fold
superior
fulllength
conjug
ntdccd
result
signific
inhibit
figur
ccdntdctd
therefor
ntd
posit
interfer
ccd
activ
ctd
appear
neg
effect
contribut
ntd
appear
necessari
support
appropri
ctd
interact
ccd
structur
analysi
show
ntd
linker
segment
residu
contribut
total
buri
ccdctd
area
figur
interestingli
carbonyl
oxygen
ntd
linker
form
hydrogen
bond
side
chain
ctd
figur
mutat
result
defect
virus
side
chain
ntd
form
hydrogen
bond
carbonyl
oxygen
ctd
figur
also
interact
side
chain
hydrogen
bond
shown
play
import
role
ledgin
induc
aberr
multimer
inde
fundament
role
ctd
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
aberr
aggreg
previous
emphas
ctd
interact
ntd
linker
residu
provid
main
dock
templat
ctd
site
buri
total
figur
therefor
ntd
linker
appear
play
crucial
role
modul
ccdctd
dock
platform
function
mutlimer
worth
explor
futur
studi
multimer
depend
delic
compat
amino
acid
line
interact
interfac
provid
attract
target
strategi
interf
interact
domain
exploit
promot
aberr
multimer
also
inhibit
assembl
function
multim
opportun
offer
ccdntd
hthcleft
ccdctd
dock
platform
report
relat
previous
identifi
pocket
observ
almost
two
decad
ago
crystal
structur
retrovir
ccd
bound
small
molecul
figur
effici
inhibit
catalyt
activ
recent
fragmentbas
screen
studi
also
captur
sever
small
molecul
bound
near
site
figur
cdq
howev
inhibitori
profil
character
inabl
peptid
bind
ccdctd
possess
expos
block
indic
dock
ctd
multimer
prefer
bind
site
ctd
involv
multimer
well
document
review
rel
orient
ctd
regard
ccd
previous
implic
function
assembl
moreov
analysi
avail
ccd
structur
bound
small
molecul
reveal
pocket
form
upon
bind
displac
flexibl
nterminu
displac
would
also
interfer
inhibit
bind
viral
dna
catalyt
activ
figur
therefor
propos
futur
structur
base
design
screen
small
molecul
interfer
ccdctd
interact
multimer
promot
format
bind
pocket
would
also
inactiv
catalyt
site
displac
aberr
configur
fact
regul
viral
integr
also
assembl
matur
viru
particl
accentu
promin
target
wherea
peptid
use
studi
may
per
se
provid
lead
hit
antiin
strategi
work
underscor
overlook
platform
potenti
therapeut
target
futur
antiin
alloster
inhibitor
construct
deriv
previous
describ
variant
subclon
plasmid
novagen
cleavabl
ntermin
histag
variou
construct
contain
follow
residu
fulllength
ntd
ccd
ntdccd
ctd
ccdctd
includ
ntd
linker
ntd
use
made
longer
previou
construct
residu
hfh
chimera
construct
confirm
dna
sequenc
construct
express
purifi
previous
describ
lysi
buffer
contain
mm
potassium
phosphat
ph
mm
imidazol
mm
nacl
fulllength
protein
fluoresc
base
activ
assay
perform
previous
describ
fab
use
molar
ratio
peptid
excess
ratio
fold
process
imosflm
structur
solv
phaser
molecular
replac
use
ccd
pdb
code
search
model
electron
densiti
fit
use
coot
refin
suit
use
structur
superposit
figur
prepar
use
pymol
molecular
graphic
system
llc
summar
data
collect
refin
statist
analys
interact
perform
use
cocomap
ligplot
lysin
crosslink
homobifunct
bs
pierc
mm
ad
fulllength
initi
mix
increas
concentr
inhibitori
peptid
acid
sigma
reaction
incub
minut
room
temperatur
quench
ad
trishcl
ph
final
concentr
mm
analyz
sdspage
affin
measur
protein
label
monolith
nt
protein
label
kit
bluenh
nanotemp
technolog
elut
microscal
thermophoresi
mst
buffer
mm
trishcl
ph
mm
nacl
label
protein
incub
serial
dilut
inhibitor
peptid
mst
measur
carri
use
monolith
standard
capillari
led
mst
power
atom
coordin
structur
factor
deposit
protein
data
bank
access
number
ctd
model
symmetri
mate
ccdctd
structur
clearli
expos
therefor
peptid
superpos
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
